Paper Details

  1. Home
  2. Paper Details

A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Author: BiondiBreanne E, CioeKatharine, EaslyRebecca, SimardAmanda, SpringerSandra A, ZhengXiao

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Opioid use disorder (OUD) is a serious public health crisis. Medications used to treat OUD include buprenorphine, methadone, and extended-release naltrexone (XR-NTX). We need to understand how patients and doctors feel about these medications, as their opinions can influence whether people get prescribed these medications, whether they stay on treatment, and whether they recover.
Paper Details　
Original Abstract of the Article :
The opioid epidemic is a public health crisis. Medications for opioid use disorder (MOUD) include: 1) buprenorphine, 2) methadone, and 3) extended-release naltrexone (XR-NTX). Research should investigate patients' and providers' perspectives of MOUD since they can influence prescription, retention, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/33138929

データ提供：米国国立医学図書館（NLM）

Medications for Opioid Use Disorder: A Patient and Provider Perspective

The opioid epidemic has cast a long shadow, leaving many struggling with addiction and seeking effective treatments. This 2020 systematic review delves into the world of medications for opioid use disorder (MOUD), exploring the perspectives of both patients and providers. MOUD, like a compass guiding a traveler through the desert, offers a path towards recovery. The review focuses on three main medications: buprenorphine, methadone, and extended-release naltrexone. The authors highlight the importance of understanding the perspectives of both patients and providers, as these can influence prescription, retention, and ultimately, the success of treatment. The review calls for further research to investigate the factors that contribute to successful engagement with MOUD and to improve the overall effectiveness of these treatments.

Understanding the Journey of Recovery

This review underscores the importance of understanding the perspectives of both patients and providers in addressing opioid use disorder. It highlights the need for a collaborative approach, ensuring that treatment plans are tailored to individual needs and preferences.

A Collaborative Path to Recovery

The journey of recovery from opioid use disorder can be challenging, but it is possible. By understanding the nuances of patient and provider perspectives, we can work together to create a more supportive and effective treatment landscape. Remember, just as a camel navigates the desert with the help of a caravan, individuals struggling with opioid use disorder need a network of support to find their way to recovery.

Dr.Camel's Conclusion

This systematic review emphasizes the importance of considering both patient and provider perspectives when addressing opioid use disorder. It highlights the need for further research to improve the effectiveness of medications for opioid use disorder and to facilitate successful engagement in treatment. The review underscores the importance of a collaborative approach, involving both patients and providers, to guide individuals on their path to recovery.

Date :
  1. Date Completed 2021-07-28
  2. Date Revised 2021-12-03
Further Info :

Pubmed ID

33138929

DOI: Digital Object Identifier

NIHMS1632412

Related Literature

Article Analysis
・Effective treatment of opioid use
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.